Decreased plasma neuropeptides in first-episode schizophrenia, bipolar disorder, major depressive disorder: associations with clinical symptoms and cognitive function
Hua Yu, Peiyan Ni, Liansheng Zhao +12 more2023Frontiers in PsychiatryJournal Article
Neurological
Abstract
Our research shows decreased circulating neuropeptides have the potential to differentiate severe mental illnesses from controls. These neuropeptides are promising treatment targets for improving clinical symptoms and cognitive function in FES, BD, and MDD.
Part of CIRS Nexus · Curated by Lauren Lowenstein, The Biotoxin Lady
Related Papers
- Association of mold exposure and solid household fuel use with depression and anxiety among older adults in ChinaEnvironmental Health · 2025 · 1 shared tag
- Pain, Fear, Anxiety, and Stress: Relations to the Endogenous Opioid SystemAdvances in neurobiology · 2024 · 1 shared tag
- Probing the VIPR2 Microduplication Linkage to Schizophrenia in Animal and Cellular ModelsFrontiers in Neuroscience · 2021 · 1 shared tag
- CGRP sensory neurons promote tissue healing via neutrophils and macrophagesNature · 2024 · 1 shared tag
- High Value Phycotoxins From the Dinoflagellate ProrocentrumFrontiers in Marine Science · 2021 · 1 shared tag
- Invited review: Mechanisms of hypophagia during diseaseJournal of Dairy Science · 2021 · 1 shared tag